Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis

Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis

Guardado en:
Detalles Bibliográficos
Autores principales: Lin Cai, Jian-Zhong Zhang, Min Zheng, Shi-Fa Zhang, Manmath Patekar, Li-Shao Guo
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer 2021
Materias:
Medicine
R
Acceso en línea:https://doaj.org/article/068df99ab5984bd8b08d4666b8358c40
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:068df99ab5984bd8b08d4666b8358c40
record_format dspace
spelling oai:doaj.org-article:068df99ab5984bd8b08d4666b8358c402021-11-25T07:57:20ZEfficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis0366-69992542-564110.1097/CM9.0000000000001710https://doaj.org/article/068df99ab5984bd8b08d4666b8358c402021-11-01T00:00:00Zhttp://journals.lww.com/10.1097/CM9.0000000000001710https://doaj.org/toc/0366-6999https://doaj.org/toc/2542-5641Lin CaiJian-Zhong ZhangMin ZhengShi-Fa ZhangManmath PatekarLi-Shao GuoWolters KluwerarticleMedicineRENChinese Medical Journal, Vol 134, Iss 21, Pp 2629-2631 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Lin Cai
Jian-Zhong Zhang
Min Zheng
Shi-Fa Zhang
Manmath Patekar
Li-Shao Guo
Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis
format article
author Lin Cai
Jian-Zhong Zhang
Min Zheng
Shi-Fa Zhang
Manmath Patekar
Li-Shao Guo
author_facet Lin Cai
Jian-Zhong Zhang
Min Zheng
Shi-Fa Zhang
Manmath Patekar
Li-Shao Guo
author_sort Lin Cai
title Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis
title_short Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis
title_full Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis
title_fullStr Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis
title_full_unstemmed Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis
title_sort efficacy and safety of secukinumab over 52 weeks in chinese psoriasis patients with concomitant psoriatic arthritis
publisher Wolters Kluwer
publishDate 2021
url https://doaj.org/article/068df99ab5984bd8b08d4666b8358c40
work_keys_str_mv AT lincai efficacyandsafetyofsecukinumabover52weeksinchinesepsoriasispatientswithconcomitantpsoriaticarthritis
AT jianzhongzhang efficacyandsafetyofsecukinumabover52weeksinchinesepsoriasispatientswithconcomitantpsoriaticarthritis
AT minzheng efficacyandsafetyofsecukinumabover52weeksinchinesepsoriasispatientswithconcomitantpsoriaticarthritis
AT shifazhang efficacyandsafetyofsecukinumabover52weeksinchinesepsoriasispatientswithconcomitantpsoriaticarthritis
AT manmathpatekar efficacyandsafetyofsecukinumabover52weeksinchinesepsoriasispatientswithconcomitantpsoriaticarthritis
AT lishaoguo efficacyandsafetyofsecukinumabover52weeksinchinesepsoriasispatientswithconcomitantpsoriaticarthritis
_version_ 1718413599504859136

Ejemplares similares